Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study - Wikidata - wikimedia - TriplyDB

Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study

Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study

http://www.wikidata.org/entity/Q33635522

about

In vivo characterization of two 18F-labeled PDE10A PET radioligands in nonhuman primate brains.

P2860

Q50200295-F80BA8F5-F9F1-492F-A7CE-55E8255F5F69

P2860

Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study

http://www.wikidata.org/entity/Q33635522

description

2017 nî lūn-bûn

@nan

2017 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մարտին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Striatal phosphodiesterase 10A ...... zophrenia: a PET and MRI study

@ast

Striatal phosphodiesterase 10A ...... zophrenia: a PET and MRI study

@en

type

label

Striatal phosphodiesterase 10A ...... zophrenia: a PET and MRI study

@ast

Striatal phosphodiesterase 10A ...... zophrenia: a PET and MRI study

@en

prefLabel

Striatal phosphodiesterase 10A ...... zophrenia: a PET and MRI study

@ast

Striatal phosphodiesterase 10A ...... zophrenia: a PET and MRI study

@en

P1433

Q33635522-8259BE59-7956-4DFC-9738-96A46AB3EB32

P1476

Q33635522-4C8F83A6-D3A4-4BD5-BF4A-9C15AB29C65D

P2093

Q33635522-0EB2E87A-F455-4303-97A1-FD36D7CCE855

Q33635522-20DC78B0-AFC5-4CB7-9D4B-A7305E0DC88B

Q33635522-42CD5EE2-FC96-49CD-A168-10D9FEB6F683

Q33635522-463890A7-25E2-4AC3-A8A3-27F28C5A3E2D

Q33635522-9A7D12DA-DA84-4342-9660-B1263FC0BB3B

Q33635522-C02DBF18-EB76-407E-8C7E-DC14B4E59A09

P2860

Q33635522-15E0081A-41C4-4DA2-B33C-A66B96ADD0A8

Q33635522-24EC06C7-CA58-43CA-AC04-ED0DFAA5AE14

Q33635522-26F1AD80-C235-4849-85CF-3A820802B5EF

Q33635522-2AF1F894-72B6-4C0E-B909-FC5F55DDE16D

Q33635522-2B7D7A55-EEEA-44D3-8533-022D6F097B54

Q33635522-34577D34-5735-4F6F-A1E5-17C288F70A68

Q33635522-39408284-3F65-4067-AD7A-48CD00EB6DCC

Q33635522-3CB5CF70-DC48-4CCF-AD34-D6093C455F84

Q33635522-3E11BD1B-494D-4FAC-A44D-7C7CCB4F5974

Q33635522-474C7C77-819F-4C5B-9380-24B848B02112

P2888

Q33635522-C534A5F2-B507-4FDE-A2B6-40CD1FCD5C3A

P304

Q33635522-934270F4-9CBA-4759-8B4A-5CA1D252D462

P31

Q33635522-07346DE6-843B-4974-8710-854D32F05C83

P356

Q33635522-98CA0A8D-B12C-4CBB-96FB-631B7E43C874

P433

Q33635522-9EE8AB50-D7FA-46E4-BED7-701DBA8A0968

P478

Q33635522-C40C0BA1-F5B8-4010-B0B0-36B07D08F306

P50

Q33635522-5A6AFFC3-90EB-416E-90AA-628B30FEE55E

P577

Q33635522-1854DA1D-4450-4161-8AA4-9A1DD0556947

P6179

Q33635522-A6A75053-89C8-4DB1-B03A-A5E6CADA5EB4

P698

Q33635522-9AE8414C-9A57-42FF-B8B7-7FE2504C2D41

P921

Q33635522-40D905C7-A136-4D67-8106-1136682D86CE

Q33635522-770B60EB-32D0-479F-A53E-9F27B63B7C1A

Q33635522-A5F0F600-E8BC-41DD-9215-26612762DF34

P932

Q33635522-158E372B-F549-48BD-A266-EF94C1EC5BA2

P356

P1433

Translational Psychiatry

P1476

Striatal phosphodiesterase 10A ...... zophrenia: a PET and MRI study

@en

P2093

A Wall

http://www.w3.org/2001/XMLSchema#string

G Antoni

http://www.w3.org/2001/XMLSchema#string

J Persson

http://www.w3.org/2001/XMLSchema#string

L Ekselius

http://www.w3.org/2001/XMLSchema#string

M Lubberink

http://www.w3.org/2001/XMLSchema#string

R Bodén

http://www.w3.org/2001/XMLSchema#string

P2860

Striatal Activity is Associated with Deficits of Cognitive Control and Aberrant Salience for Patients with Schizophrenia.

Cortical Surface-Based Analysis

The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings

Phosphodiesterase 10A inhibitor MP-10 effects in primates: comparison with risperidone and mechanistic implications

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system

Unified segmentation

Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.

Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.

P2888

P304

e1050

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TP.2017.11

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Elna-Marie Larsson

P577

2017-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084133401

http://www.w3.org/2001/XMLSchema#string

P698

28267149

http://www.w3.org/2001/XMLSchema#string

P921

corpus striatum

cortical thickness

P932

5416662

http://www.w3.org/2001/XMLSchema#string